111, Inc. Announces First Quarter 2025 Unaudited Financial Results

111, Inc. (YI) reported relatively flat net revenues of RMB3.5 billion (US$486.3 million) for Q1 2025, while maintaining operational profitability and positive operating cash flow. The company reduced total operating expenses by 4.8% year-over-year, driven by decreases in selling and marketing and technology expenses, reflecting improved operational efficiency; however, income from operations decreased to RMB0.1 million from RMB3.7 million in the same quarter last year. Management remains focused on leveraging technology and AI to enhance its healthcare value chain and capture long-term market opportunities.

Analysis

111, Inc. (YI) reported stable net revenues of RMB3.5 billion for Q1 2025, consistent with the prior year, while successfully maintaining positive operating cash flow at RMB112.6 million. The company demonstrated improved operational efficiency, evidenced by a 4.8% year-over-year reduction in total operating expenses to RMB195.0 million, which as a percentage of net revenues decreased by 30 basis points to 5.5%. This cost discipline was primarily driven by double-digit percentage decreases in selling, marketing, and technology expenses. However, this operational leverage did not translate into enhanced profitability, as GAAP income from operations drastically fell to RMB0.1 million from RMB3.7 million year-over-year, and Non-GAAP income from operations declined to RMB4.3 million from RMB8.9 million. Segment performance was divergent: the B2B segment achieved a marginal 0.6% year-over-year revenue increase to RMB3.47 billion, but its segment profit margin contracted slightly to 5.3% from 5.5%. In contrast, the B2C segment experienced a significant 28.0% decline in net revenue to RMB55.0 million, with its segment profit margin deteriorating sharply to 17.4% from 23.1%. Fulfillment expenses also rose by 5.7% and constituted 2.7% of net revenues, up from 2.5% in the prior year, partially offsetting savings in other opex categories. Consequently, the company's net loss widened to RMB7.3 million from RMB2.7 million, and it reported a Non-GAAP net loss of RMB3.2 million, a reversal from a Non-GAAP net profit of RMB2.5 million in Q1 2024. Management attributes these results to navigating a persistently challenging macroeconomic environment and remains focused on leveraging technology and AI for long-term growth, though the provided signals indicate a moderately negative sentiment and a cautious market tone, with InvestingPro noting YI was not a top-ranked undervalued stock.

Key Decisions for Investors

• Investors should closely monitor the B2C segment's performance for signs of stabilization or continued decline, and assess whether the B2B segment can reverse its margin compression in the upcoming quarters.
• Exercise caution due to the significant decrease in both GAAP and Non-GAAP operating income and the shift to a Non-GAAP net loss, despite achievements in operational cost reductions; future performance needs to demonstrate a clear path back to bottom-line profitability.
• Evaluate the company's valuation in the context of flat revenue, deteriorating profitability, and the execution risks associated with its technology-driven strategy, particularly given the challenging macroeconomic backdrop and the moderately negative market sentiment.